Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Neuropsychiatr Dis Treat ; 18: 3001-3022, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36578903

RESUMEN

"Myasthenia Gravis is, like it or not, the neurologist's disease!" (Thomas Richards Johns II, MD Seminars in Neurology 1982). The most common disorders in clinical practice involving defective neuromuscular transmission are myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS). The hallmark of weakness related to malfunction of the neuromuscular junction (NMJ) is variability in severity of symptoms from minute to minute and hour to hour. Fatigable weakness and fluctuation in symptoms are common in patients whether the etiology is autoimmune, paraneoplastic, genetic, or toxic. Autoimmune MG is the most common disorder of neuromuscular transmission affecting adults with an estimated prevalence of 1 in 10,000. While LEMS is comparatively rare, the unique clinical presentation, the association with cancer, and evolving treatment strategies require the neurologist to be familiar with its presentation, diagnosis, and management. In this paper we provide a summary of the meaningful recent clinical developments in the diagnosis and treatment of both MG and LEMS.

2.
Arch Oral Biol ; 60(7): 1021-9, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25889171

RESUMEN

OBJECTIVE: The inhibitory neurotransmitter γ-aminobutyric acid (GABA) plays an important role in the pathophysiology of anxiety behavioural disorders such as panic disorder and post-traumatic stress disorder and is also implicated in the manifestation of tooth-grinding and clenching behaviours generally known as bruxism. In order to test whether the stress-related behaviours of tooth-grinding and clenching share similar underlying mechanisms involving GABA and other metabolites as do anxiety-related behavioural disorders, we performed a Magnetic Resonance Spectroscopy (MRS) study for accurate, in vivo metabolite quantification in anxiety-related brain regions. DESIGN: MRS was performed in the right hippocampus and right thalamus involved in the hypothalamic-pituitary-adrenal axis system, together with a motor planning region (dorsal anterior cingulate cortex/pre-supplementary motor area) and right dorsolateral prefrontal cortex (DLPFC). Eight occlusal splint-wearing men (OCS) with possible tooth-grinding and clenching behaviours and nine male controls (CON) with no such behaviour were studied. RESULTS: Repeated-measures ANOVA showed significant Group×Region interaction for GABA+ (p = 0.001) and glutamate (Glu) (p = 0.031). Between-group post hoc ANOVA showed significantly lower levels of GABA+ (p = 0.003) and higher levels of Glu (p = 0.002) in DLPFC of OCS subjects. These GABA+ and Glu group differences remained significant (GABA+, p = 0.049; Glu, p = 0.039) after the inclusion of anxiety as a covariate. Additionally, GABA and Glu levels in the DLPFC of all subjects were negatively related (Pearson's r = -0.75, p = 0.003). CONCLUSIONS: These findings indicate that the oral behaviours of tooth-grinding and clenching, generally known as bruxism, may be associated with disturbances in brain GABAergic and glutamatergic systems.


Asunto(s)
Encéfalo/metabolismo , Bruxismo/metabolismo , Bruxismo/prevención & control , Ácido Glutámico/metabolismo , Espectroscopía de Resonancia Magnética , Ferulas Oclusales , Ácido gamma-Aminobutírico/metabolismo , Adulto , Química Encefálica , Estudios de Casos y Controles , Humanos , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios
3.
Muscle Nerve ; 43(5): 648-51, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21484823

RESUMEN

INTRODUCTION: An association is observed between the severity of myotonic dystrophy type 1 (DM1) and the genetic abnormality of cytosine-thymine-guanine (CTG) repeat expansion. It is unknown whether an association exists between survival and CTG repeat expansion. METHODS: In an adult 406-patient DM1 cohort, the phenotype, including survival age, was evaluated in relation to CTG repeat expansion. RESULTS: At study entry, age was 42 ± 12 (range 18-78) years, with a CTG repeat length of 629 ± 386 (range 54-1965). An inverse correlation was observed between CTG repeat length and the age at onset and younger DM1 phenotype. Over a follow-up of 9.2 ± 3.1 years, 118 (29.1%) patients died, including 60 of neuromuscular respiratory failure, 41 of cardiac causes, and 17 of non-neuromuscular, non-cardiac causes. There was an inverse relationship between all-cause survival and CTG length (relative risk 5.4 per log repeat, 95% confidence interval 2.9-10.2, P < 0.001). CONCLUSION: The data demonstrate a genotype-mortality association in DM1.


Asunto(s)
Citosina , Guanina , Timina , Expansión de Repetición de Trinucleótido/genética , Adolescente , Adulto , Anciano , Estudios de Cohortes , Citosina/química , Femenino , Estudios de Seguimiento , Guanina/química , Humanos , Masculino , Persona de Mediana Edad , Distrofia Miotónica/genética , Distrofia Miotónica/metabolismo , Distrofia Miotónica/mortalidad , Tasa de Supervivencia/tendencias , Timina/química , Adulto Joven
4.
Semin Neurol ; 31(1): 42-53, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21321832

RESUMEN

In an outpatient neurologic practice, the patient complaint of being "tired" is frequently encountered yet often not specifically addressed. Clarifying the symptoms and determining whether the tiredness is the result of excessive daytime sleepiness versus fatigue or weakness is the first step in diagnosing and treating the patient. A detailed neurologic and sleep history and exam can often distinguish among these different symptoms, establish the potential causes of excessive sleepiness, and decide on the additional ancillary tests that may be helpful to determine the underlying etiology. Understanding the etiology of patient's symptoms is necessary to initiate appropriate treatment.


Asunto(s)
Trastornos de Somnolencia Excesiva/diagnóstico , Fatiga/diagnóstico , Visita a Consultorio Médico , Síndromes de la Apnea del Sueño/diagnóstico , Trastornos de Somnolencia Excesiva/fisiopatología , Trastornos de Somnolencia Excesiva/terapia , Fatiga/fisiopatología , Fatiga/terapia , Humanos , Polisomnografía/métodos , Polisomnografía/normas , Síndromes de la Apnea del Sueño/fisiopatología , Síndromes de la Apnea del Sueño/terapia , Trastornos del Sueño-Vigilia/diagnóstico , Trastornos del Sueño-Vigilia/fisiopatología , Trastornos del Sueño-Vigilia/terapia
5.
J Clin Neurophysiol ; 26(1): 45-9, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19151616

RESUMEN

The presence of afterdischarges on repetitive nerve stimulation may be useful to diagnose cramp fasciculation syndrome, however, the presence and normal duration of afterdischarges has not been well-defined in the normal population and individuals with other neuromuscular diseases. The aim of this pilot study was to describe the distribution of afterdischarge durations in normal controls and patients with peripheral neuropathy. The estimated seventy-fifth percentiles of the afterdischarge durations following tibial nerve repetitive nerve stimulation at 2, 5, 10, and 20 Hz were 315, 688, 745, and 928 milliseconds for 18 normal patients, and 143, 31, 323, and 542 milliseconds for 18 peripheral neuropathy patients respectively. Afterdischarge durations were similar in peripheral neuropathy patients and controls. These findings suggest that afterdischarge durations of more than 500 milliseconds are common in normal controls without subjective cramps and patients with peripheral neuropathy, with some durations beyond 1,000 milliseconds. Therefore, the presence of afterdischarges on repetitive nerve stimulation should be interpreted with caution when evaluating patients for hyperexcitable nerve syndromes.


Asunto(s)
Enfermedades del Sistema Nervioso Periférico/fisiopatología , Nervio Tibial/fisiopatología , Adulto , Fasciculación/etiología , Fasciculación/fisiopatología , Femenino , Humanos , Masculino , Calambre Muscular/etiología , Calambre Muscular/fisiopatología , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Proyectos Piloto , Estimulación Eléctrica Transcutánea del Nervio
6.
J Womens Health (Larchmt) ; 18(12): 1955-63, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20044857

RESUMEN

Rapid eye movement (REM) sleep behavior disorder (RBD) is a treatable parasomnia involving dream-enacting behaviors that is considered to be a male-predominant disorder. However, it is speculated that underrecognition of RBD among female patients in part contributes to the male predominance, probably because women have less aggressive and violent RBD behaviors. We conducted a literature review focused primarily on women with RBD, in which the age of onset of RBD, types of nocturnal behaviors, presence of dream enactment, polysomnographic findings, clinical course, treatment response, male/female ratio, comorbid diagnoses, and medications were tabulated and discussed. RBD was found to primarily affect middle-aged and older women and those with a broad range of neurological disorders. As the link between RBD and neurodegenerative disorders, such as Parkinson's disease, becomes increasingly apparent, including the delayed emergence of parkinsonism in patients initially diagnosed with idiopathic RBD, primary care and specialty physicians should be aware of RBD in women, its potential complications, its excellent response to clonazepam, and its association with neurological disorders and older age groups.


Asunto(s)
Pautas de la Práctica en Medicina , Trastorno de la Conducta del Sueño REM/diagnóstico , Trastorno de la Conducta del Sueño REM/tratamiento farmacológico , Salud de la Mujer , Clonazepam/uso terapéutico , Diagnóstico Diferencial , Progresión de la Enfermedad , Diagnóstico Precoz , Femenino , Moduladores del GABA/uso terapéutico , Humanos , Masculino , Enfermedades Neurodegenerativas/diagnóstico , Enfermedades Neurodegenerativas/tratamiento farmacológico , Enfermedad de Parkinson/tratamiento farmacológico , Enfermedad de Parkinson/etiología , Guías de Práctica Clínica como Asunto , Atención Primaria de Salud/organización & administración , Trastorno de la Conducta del Sueño REM/etiología , Índice de Severidad de la Enfermedad
8.
Parkinsonism Relat Disord ; 12(1): 1-7, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16399043

RESUMEN

Restless legs syndrome (RLS) is a common disorder, although under-diagnosed, with a prevalence of up to 15% depending on the population sampled. Familial aggregation has been widely shown since Ekbom formerly described the condition in 1960; twin studies support a genetic contribution in the development of this disorder. Molecular genetic approaches have identified three genomic regions in RLS susceptibility, however no specific mutations have yet been identified. Herein, we review the current status of genetics in RLS, providing some methodological guidelines to help future research.


Asunto(s)
Síndrome de las Piernas Inquietas/genética , Frecuencia de los Genes , Ligamiento Genético/genética , Humanos , Síndrome de las Piernas Inquietas/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...